Memphasys - Reproductive Biotechnology

Memphasys - Reproductive Biotechnology To achieve our goal of better technology, more life Memphasys combines qualified, experience, and technology in reproductive biotechnology.

Memphasys Reproductive Biotechnology (ASX: MEM) will be attending the 42nd Annual Meeting of the European Society of Hum...
01/07/2026

Memphasys Reproductive Biotechnology (ASX: MEM) will be attending the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) in London from 5–8 July 2026.

Visit us at Booth D53b to learn more about FELIX™ and hear about the latest clinical, regulatory and commercial milestones supporting its growing adoption across global fertility markets.

Whether you are an embryologist, clinician, fertility specialist, researcher or industry partner, we welcome the opportunity to connect, exchange insights and discuss the future of fertility care.

If you're attending ESHRE, we'd love to meet with you.

📍 Booth D53b | ESHRE | London
📅 5–8 July 2026

Memphasys’ direct-sales strategy in the Middle East & North Africa has moved from launch to live ex*****on.Following the...
09/12/2025

Memphasys’ direct-sales strategy in the Middle East & North Africa has moved from launch to live ex*****on.
Following the Middle East Fertility Society (MEFS) Conference (4–6 December), A/Prof Hassan Bakos PhD MBA - who delivered a keynote address comparing Felix™ performance to DGC and Swim-Up methods - progressed directly into clinic-level commercial engagement.
Yesterday, Hassan toured key UAE fertility centres, converting conference demand into distributor readiness, onboarding discussions and procurement momentum.
This follows a strong week in Doha, including an International Technical Legacy (ITL)-sponsored Felix™ launch event and clinician-focused seminars.
Hassan is today heading back to Australia after two weeks of intensive market activation and commercial ex*****on.
Commercial traction continues to build!

Felix™️ System Launched in the Middle East and North Africa. Memphasys’ Felix™️ direct-sales strategy in Middle East Nor...
05/12/2025

Felix™️ System Launched in the Middle East and North Africa. Memphasys’ Felix™️ direct-sales strategy in Middle East North Africa (MENA) is in full motion.

Memphasys Director - Clinical Partnerships and Growth, A/Prof Hassan Bakos PhD MBA is currently onsite for the Middle East Fertility Society (MEFS) conference (4th- 6th December). This puts Felix™️ directly in front of the most important audience: senior clinicians, scientists and distributors.

MEFS provides direct access to the clinical and procurement leaders who drive adoption and deployment. On 6 December, A/Prof Hassan will deliver a keynote presentation reinforcing Felix™️’s clinical strength and opening direct sales channels.

This comes after an intensive and highly productive week for A/Prof Bakos - delivering an ITL-sponsored Felix™️ Seminar in Doha and multiple clinic visits.

Following the conference conclusion, A/Prof Bakos will conduct a tour across the United Arab Emirates, a key commercial market for Memphasys to drive commercial sales in the region.

Commercial momentum continues!

Memphasys’ Felix™️ device officially launched in Qatar. Direct-sales strategy in MENA is now fully activated.Memphasys D...
04/12/2025

Memphasys’ Felix™️ device officially launched in Qatar. Direct-sales strategy in MENA is now fully activated.

Memphasys Director - Clinical Partnerships & Growth, A/Prof Hassan Bakos PhD MBA, is in Dubai on-site preparing direct engagement with the region’s senior stakeholders who determine adoption pathways and purchasing decisions.

Earlier this week in Doha, International Technical Legacy (ITL) sponsored a Felix™️ launch event introducing the device to Qatar’s market with representatives from the majority of clinics attending the launch event. The response was highly positive, generating strong engagement, follow-up requests, and actionable commercial interest.

So far, the busy week has also included:
- a Felix™️ Launch Seminar at Plaza Doha
- multiple targeted clinic visits and demonstrations
- a full-day engagement at Hamad Medical Corporation (HMC), Qatar’s largest ART centre

A/Prof Bakos is now gearing up for the Middle East Fertility Society (MEFS) Conference in Dubai on 4–6 December, where Felix™️ will be positioned directly in front of key stakeholders across the whole of the MENA region.

Commercial momentum is accelerating!

Commercial Acceleration in the Middle East. Our new direct-sales strategy, giving us greater control over ex*****on, is ...
04/12/2025

Commercial Acceleration in the Middle East. Our new direct-sales strategy, giving us greater control over ex*****on, is now in full motion.

Memphasys Director - Clinical Partnerships and Growth, A/Prof Hassan Bakos PhD MBA, is in Doha leading on-site Felix™ commercial planning at ITL preparing them to go direct and engaging their clinic networks and drive demand beyond the $390K minimum order quantity.

This marks the first phase of an intensive business-development push across the region, culminating at the Middle East Fertility Society (MEFS) conference in Dubai, one of the Middle East’s most influential fertility conferences, where Hassan will take the stage as a keynote speaker to the region’s leading clinical decision-makers.

First up, Bakos undertook a full-day visit of the Hamad Medical Corporation (HMC), the largest ART center in Qatar. Partner readiness. Client engagement. Commercial momentum. More updates soon!

Address

30 Richmond Road
Homebush West, NSW
2140

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+61284157300

Website

Alerts

Be the first to know and let us send you an email when Memphasys - Reproductive Biotechnology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Memphasys - Reproductive Biotechnology:

Shortcuts

Share

Category